Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

ABIOMED Inc (ABMD-RM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ABIOMED historical data, for real-time data please try another search
23,629.00 0.00    0.00%
22/02 - Real-time Data. Currency in RUB ( Disclaimer )
Type:  Equity
Market:  Russia
ISIN:  US0036541003 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 23,629.00 - 23,629.00
ABIOMED 23,629.00 0.00 0.00%

ABIOMED Inc Company Profile

 
Get an in-depth profile of ABIOMED Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
Industry
Sector
Employees

2003

Equity Type

ORD

Abiomed, Inc. engages in the research, development, manufacturing, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro-heart pump with an integrated motor and sensors, and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro-heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; the Impella SmartAssist platform, which includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staff; and the OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in Germany, France, the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts with additional offices in Halethorpe, Maryaland; Aachen and Berlin, Germany; Woburn, Massachusetts; and Tokyo, Japan. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

Contact Information

Address 22 Cherry Hill Drive
Danvers, 01923
United States
Phone 978-646-1400
Fax 978-777-8411
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABMD Comments

Write your thoughts about ABIOMED Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Raul AlKhuwaitem
Raul AlKhuwaitem Aug 10, 2021 12:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TKAT, SOS, ZKIN, FTFT, Crypto companies will get huge gain soon.. Bitcoin start shining again.. Be ready to reach February picks.. Buy and hold forever..
TECK CHUAN HO
TECK CHUAN HO May 08, 2020 5:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Under 170.00
vaibhav sharma
vaibhav sharma May 08, 2020 5:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
post your reasons.
Johnny Fan Hui
Johnny Fan Hui Apr 30, 2020 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what just happened?! this popped 10% today
Le Vent Goldberg
Le Vent Goldberg Feb 13, 2020 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Guys what is wrong with this stock?
News Feed
News Feed Jan 13, 2020 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to collect
WTI Trader
WTI Trader Jan 13, 2020 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When?
kyN Ch
kkyN Jan 13, 2020 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ok so whats happening again
News Feed
News Feed Jan 13, 2020 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to collect
Ιδομενέας ΒΣ
Ιδομενέας ΒΣ Jan 06, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think so ..it's undervalued
easy money
easy money Nov 28, 2019 3:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DO YOU think ti will rise to 250 usd ? soon or very late ?
Xpeng Trader
Xpeng Trader Nov 28, 2019 3:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No will drop to $155
Rahul Jadhav
Rahul Jadhav Nov 23, 2019 6:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a report suggested that impella product from abmd is no good.
kyN Ch
kkyN Nov 18, 2019 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone knows why the drastic drop?
Naim Katiman
Naim Katiman Nov 18, 2019 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
curious either on why?
Rahul Jadhav
Rahul Jadhav Nov 18, 2019 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a report suggested that impella product from abmd is no good.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email